Summary of Henry Schein (HSIC) 2025 Conference Call Company Overview - **Company**: Henry Schein, Inc. (HSIC) - **Date of Conference**: May 29, 2025 - **Key Speakers**: Ron South (CFO), Andrea Albertini (CEO, Global Distribution and Technology), Tom Popack (CEO, Henry Schein Products Groups) Key Industry Insights - **Market Recovery**: After a slow January attributed to weather, there was a notable recovery in February and March, with positive trends observed in both dental and medical sectors [2][5][7] - **Regulatory Uncertainty**: The introduction of tariffs and regulatory changes has created uncertainty in the market, affecting customer navigation and supplier dynamics [4] - **Dental and Medical Stability**: The dental market remains stable, while the medical sector saw an uptick due to a late flu season, leading to increased sales of diagnostic kits [5] Core Business Initiatives - **Specialty Products Sales**: The distribution sales force is now selling specialty products, particularly in the endodontic business, which has shown strong market share and momentum [9][10][13] - **Implant Market Growth**: The company is experiencing mid to high single-digit growth in the implant market in Europe, while the U.S. market remains relatively flat due to macroeconomic conditions [20][22] - **Global E-commerce Platform**: A new e-commerce platform was launched in the UK and Ireland, with plans for a broader rollout in the U.S. and Canada in 2026. This initiative aims to enhance customer experience and operational efficiency [25][31] Financial Performance and Projections - **Long-term Growth Goals**: The company aims for 8% to 11% EPS growth, contingent on achieving 6% to 8% top-line growth, which is currently challenged by lower market growth rates in core dental and medical sectors [34][35] - **Restructuring Savings**: A restructuring plan initiated last year is expected to yield annual savings of $75 million to $100 million, contributing positively to the cost base by the end of 2025 [37] - **Technology Segment Growth**: The technology segment is expected to return to high single-digit growth, driven by the transition from on-premise to SaaS models, despite current low single-digit growth rates [44][46] Market Challenges and Opportunities - **DSO Relationships**: The company emphasizes the importance of strategic partnerships with Dental Service Organizations (DSOs) to drive profitability rather than engaging in price competition [56][58] - **Medical Segment Growth**: The medical business is projected to achieve a CAGR of 4% to 7%, with home solutions contributing significantly to this growth [61][62] - **KKR Involvement**: KKR's investment is expected to enhance operational efficiency and revenue enhancement initiatives, although it is still in the early stages of collaboration [63][64] Additional Insights - **Equipment Orders**: There is optimism regarding equipment orders, although macroeconomic concerns may lead to delays in installations and revenue recognition [40][41] - **Customer Experience Focus**: The company is working on improving customer experience through loyalty programs and targeted promotions, particularly for online shoppers [30][28] This summary encapsulates the key points discussed during the Henry Schein conference call, highlighting the company's performance, strategic initiatives, and market outlook.

Henry Schein (HSIC) 2025 Conference May 14, 2025 01:00 PM ET Speaker0 Welcome to day two of the BofA Healthcare Conference. My name is Alan Lutz. I run Healthcare Tech and Distribution here at BofA. We are very excited to welcome Henry Schein. We have CFO Ron South. Ron, thank you for joining us. Speaker1 Thank you, Al. Speaker0 I wanted to start talking about recent dental trends that you're seeing in the market. So if we go back to the call from, I believe, last week, talked about January, some weather re ...

Core Viewpoint - Henry Schein, Inc. (HSIC) reported adjusted earnings per share (EPS) of $1.15 for Q1 2025, reflecting a 4.5% increase year-over-year and exceeding the Zacks Consensus Estimate by 3.6% [1][12] Financial Performance - The company recorded a GAAP EPS of 88 cents, up from 72 cents in the same quarter last year [2] - Q1 revenues were $3.17 billion, a slight decline of 0.1% year-over-year, and fell short of the Zacks Consensus Estimate by 1.8% [3] - Constant currency total net sales increased by 1.4%, while excluding PPE and COVID-19 test kits, sales growth was 2% year-over-year [3] Segment Analysis - Global Distribution and Value-Added Services segment sales decreased by 0.7% to $2.68 billion, with a 0.8% increase in constant currencies [4] - Global Dental Distribution merchandise sales rose by 0.4% in constant currencies, while equipment sales fell by 2.4% due to sales deferrals [5] - Global Medical Distribution sales increased by 3% in constant currencies, driven by higher patient traffic and growth from acquisitions [5] - Global Specialty Products segment sales totaled $367 million, up 2% on a reported basis [6] - Global Technology segment sales reached $162 million, reflecting a 2.9% increase on a reported basis [7] Margin and Liquidity - Gross profit for the quarter was $1.00 billion, a 1.2% decrease year-over-year, with gross margin contracting to 31.6% [8] - SG&A expenses decreased by 6.7% to $738 million, while adjusted operating profit rose by 18.6% to $262 million [8] - The company ended Q1 2025 with cash and cash equivalents of $127 million, up from $122 million at the end of Q4 2024 [9] Share Repurchase and Guidance - HSIC repurchased approximately 2.3 million shares at an average price of $71.58, totaling around $161 million, with $718 million available for future repurchases [10] - The company maintained its adjusted EPS forecast for 2025 in the range of $4.80-$4.94, indicating 1-4% growth from 2024 [11] Strategic Outlook - HSIC is advancing its BOLD+1 Strategic Plan for 2025 to 2027, focusing on operational efficiency, enhancing customer experience, and expanding its digital solutions [13]

Henry Schein (HSIC) Q1 2025 Earnings Call May 05, 2025 08:00 AM ET Speaker0 Good morning, ladies and gentlemen. Welcome to Henry Schein's First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. Later, we'll conduct a question and answer session. Please press the star key followed by one on your touch tone phone if you'd like to ask a question at the end of the call. If anyone should require operator assistance during the call, please press the star ...

1 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Q1 2025 Earnings Conference Call In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. Financial Results & Outlook All forward-lo ...